130 related articles for article (PubMed ID: 8707737)
1. Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis.
Cartledge JD; Midgley J; Gazzard BG
J Antimicrob Chemother; 1996 Feb; 37(2):275-83. PubMed ID: 8707737
[TBL] [Abstract][Full Text] [Related]
2. Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
Cartledge JD; Midgley J; Petrou M; Shanson D; Gazzard BG
J Antimicrob Chemother; 1997 Oct; 40(4):517-23. PubMed ID: 9372421
[TBL] [Abstract][Full Text] [Related]
3. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
Cartledge JD; Denning DW; Dupont B; Clumeck N; De Wit S; Midgley J; Hawkins DA; Gazzard BG
AIDS; 1998 Mar; 12(4):411-6. PubMed ID: 9520171
[TBL] [Abstract][Full Text] [Related]
4. Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidosis.
Cartledge JD; Midgley J; Gazzard BG
AIDS; 1997 Feb; 11(2):163-8. PubMed ID: 9030362
[TBL] [Abstract][Full Text] [Related]
5. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
Chryssanthou E; Torssander J; Petrini B
Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
[TBL] [Abstract][Full Text] [Related]
6. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole resistant oral candidiasis in HIV-infected patients.
Tumbarello M; Tacconelli E; Caldarola G; Morace G; Cauda R; Ortona L
Oral Dis; 1997 May; 3 Suppl 1():S110-2. PubMed ID: 9456668
[TBL] [Abstract][Full Text] [Related]
8. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole.
Ruhnke M; Eigler A; Engelmann E; Geiseler B; Trautmann M
Infection; 1994; 22(2):132-6. PubMed ID: 8070927
[TBL] [Abstract][Full Text] [Related]
9. Clinical response to ketoconazole of HIV-related oral candidosis is predicted by Odds' relative growth method of susceptibility testing.
Cartledge JD; Midgley J; Gazzard BG
J Antimicrob Chemother; 1997 Jul; 40(1):117-9. PubMed ID: 9249214
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
[TBL] [Abstract][Full Text] [Related]
11. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
[TBL] [Abstract][Full Text] [Related]
12. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.
Lacassin F; Damond F; Chochillon C; Longuet P; Lebras J; Vilde JL; Leport C
Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316
[TBL] [Abstract][Full Text] [Related]
13. Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients.
Masiá Canuto M; Gutiérrez Rodero F; Ortiz de la Tabla Ducasse V; Hernández Aguado I; Martín González C; Sánchez Sevillano A; Martín Hidalgo A
Eur J Clin Microbiol Infect Dis; 2000 Aug; 19(8):593-601. PubMed ID: 11014621
[TBL] [Abstract][Full Text] [Related]
14. Oral Candida isolates among HIV-infected subjects in Nigeria.
Nweze EI; Ogbonnaya UL
J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
[TBL] [Abstract][Full Text] [Related]
15. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
[TBL] [Abstract][Full Text] [Related]
16. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Eichel M; Just-Nübling G; Helm EB; Stille W
Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
[TBL] [Abstract][Full Text] [Related]
18. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons.
Koks CH; Meenhorst PL; Bult A; Beijnen JH
Pharmacol Res; 2002 Aug; 46(2):195-201. PubMed ID: 12220961
[TBL] [Abstract][Full Text] [Related]
20. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
Revankar SG; Kirkpatrick WR; McAtee RK; Dib OP; Fothergill AW; Redding SW; Rinaldi MG; Patterson TF
J Infect Dis; 1996 Oct; 174(4):821-7. PubMed ID: 8843222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
